Skip to main content
Premium Trial:

Request an Annual Quote

Rescentris, Tripos, caBIG, Nonlinear Dynamics, DNAStar, Ariadne Genomics, Media Cybernetics, Geospiza, Ingenuity, Agilent Technologies, Virginia Bioinformatics Institute, MDL

Premium

Rescentris Secures Series A Funding

Rescentris, a provider of electronic laboratory notebook software, said this week that it has completed its Series A financing.

The company did not disclose the amount of funding, but CSO Jeff Spitzner told BioInform via e-mail that it is "sufficient to support us fully for two years of current operations completely independent of the added revenues we'll be bringing in."

The company will use the financing to expand its sales and marketing programs and further development of its flagship product, the Collaborative Electronic Research Framework (CERF).

Initial development of CERF was funded in part by a grant from the State of Ohio's Third Frontier Project, Rescentris said.

The product was developed in collaboration with Ohio State University's BioMedical Informatics department.


Tripos Raises $5.5M in Stock Sale

Tripos said this week that it has sold 1.8 million shares at a price of $3.00 per share and issued 550,000 five-year common stock warrants exercisable at $3.50 per share to Midwood Capital, a Boston-based investment partnership.

Proceeds from the transaction total $5.5 million before expenses.

The shares represent around 18 percent of Tripos' outstanding common stock, the company said. The stock bears a dividend at an annual rate of 10.5 percent and is redeemable in two years.

Seven Hills Partners, a financial advisory firm that Tripos retained earlier this year [BioInform 01-13-06], acted as the placement agent for the financing.

Tripos said it is continuing to work with Seven Hills Partners to explore "strategic alternatives to maximize shareholder value and enhance growth prospects" for both its Discovery Research and Discovery Informatics businesses. The company added that it does not plan to make future comments on this process unless there are "material developments."


NCI's caBIG Seeks Subcontractor for caArray Development

The National Cancer Institute Center for Bioinformatics Cancer Array Informatics Project, called caArray, is seeking a subcontractor to assist with development of the software platform.

The solicitation notice is available at http://www.fbo.gov/spg/HHS/NIH/FCRF/S06%2D241/Attachments.html.

The caArray project includes a microarray database and data analysis and visualization tools, and NCICB said it is seeking a subcontractor with "adequate database support, domain knowledge in microarray, technical leadership, and program management services."

The subcontractor "will include test plan development, software quality assurance procedures, and professional project management activities in its planning and execution," NCICB said.


University of York Adopts Nonlinear's 2D Gel Analysis Software

Nonlinear Dynamics said this week that the University of York's biology department hFinancial terms of the agreement were not disclosed.

Financial terms of the agreement were not disclosed.


DNAStar Launches Matching-Grant Program for Lasergene Software

DNAStar said this week that it has launched a grant program designed to help small colleges acquire its Lasergene sequence analysis software.

Eligible colleges or universities can receive up to $2,500 in matching funds towards the purchase of Lasergene software, the company said.

DNAStar has made an initial commitment of $100,000 in matching funds for the program.


Institute Curie Licenses Ariadne's PathwayStudio

Ariadne Genomics said this week that Institut Curie has licensed its PathwayStudio pathway-analysis software.

The institute's Cancer Research Center will use the software to study tumor development, tumor classification, and treatment customization, the company said.

"One of our main purposes is to better classify, diagnose and prognose tumors, and to adapt treatments to individual patients," said Emmanuel Barillot, director of bioinformatics at Institut Curie, in a statement.


Media Cybernetics Acquires Assets of AutoQuant

Image-analysis software provider Media Cybernetics said this week that it has acquired the assets of AutoQuant, a software firm that specializes in deconvolution algorithms for quantitative microscopy.

Financial terms of the acquisition were not provided.

AutoQuant's software products "will continue to be available via authorized reseller channels worldwide," Media Cybernetics said in a statement. The company said it will provide existing AutoQuant software customers with "ongoing support, maintenance and further development of the AutoQuant product line."


SeqWright Deploys Geospiza's Finch Suite

Geospiza said this week that sequencing services shop SeqWright has deployed its Finch Suite data-management software into commercial production.

SeqWright will use the Finch Suite to increase the scale of its IT infrastructure "in response to a growing market demand for services," Geospiza said.

The Finch suite "is simplifying the way our customers place orders and how our laboratory technicians manage their day-to-day workflow and data distribution processes," said Ken Paynter, operations director at SeqWright, in a statement.


Ingenuity to Integrate IPA with Agilent's GeneSpring

Ingenuity Systems and Agilent Technologies said this week that they have integrated Agilent's GeneSpring software with Ingenuity Pathways.

Agilent has released GeneSpring GX-IPA connector scripts at http://www.chem.agilent.com/scripts/generic.asp?lpage=41630&indcol=N&prodcol=N.

The connector tool enables users to integrate GeneSpring GX version 7.3 and later with IPA 3.3 and includes three scripts that allow users to send gene lists with experimental data for analysis in IPA and create networks of interacting genes and proteins.


Shanghai Bioinformatics Center to Use Egenera Blade System

Egenera, a blade server provider, said this week that the Shanghai Center for Bioinformation Technology will deploy its system "in cities throughout China."

SCBT's new public service platform "consists of more than 10 sub-systems running various applications," said Yixue Li, director of SCBT, in a statement.

"Because these applications are complex, mission-critical and frequently modified, a virtualized, easily managed platform was needed," he said.

Further details of the deployment were not provided.


VBI Teams with Brazilian Institute to Develop Infectious Disease Products

The Virginia Bioinformatics Institute and a Brazilian health institute this week said they plan to develop a wide range of medical products and technologies.

The initial three-year alliance calls for the VBI and the Oswaldo Cruz Foundation to develop drugs, vaccines, diagnostics, and "other technologies" for infectious diseases, including dengue fever, hepatitis C, HIV/AIDS, influenza, malaria, and pneumonia.

Details of the agreement were not disclosed.

FIOCRUZ, based in Rio de Janeiro, has expertise in biology, medicine, and the epidemiology of infectious diseases, while VBI is known for its genomics, proteomics, and bioinformatics tools and data.


Symyx Joins MDL Isentris Alliance

Symyx Technologies, a provider of material science software, has joined the MDL Isentris Alliance, a consortium led by Elsevier MDL to develop integrated R&D workflows based on the MDL Isentris platform.

Other companies in the alliance include Spotfire, Tripos, InfoChem, InforSense, Klee, Aston, and DeltaSoft.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.